Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

UCB

Tracked across 3 events · 50 articles · First seen Jul 13, 2026 · Last active Sep 04, 2026

Sentiment
33
Attention
6
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 40
Business
Impact: UCB obtained worldwide exclusive license to develop and commercialize ATG-201, expanding its autoimmune disease pipeline. The upfront payment and potential milestones represent a strategic investment.
Jul 13, 2026 · 7 articles
6 40
Domestic
On August 31, 2026, President Donald Trump announced voluntary drug pricing agreements with nine pharmaceutical companies: Alcon, Astellas Pharma, BeOne Medicines, BridgeBio Pharma, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB. These companies agreed…
Impact: UCB joined the MFN pricing agreement, offering drugs at reduced prices to United States — Medicaid. This could impact U.S. sales but secures tariff exemptions.
Aug 18, 2026 · 37 articles
2 20
Business
Impact: UCB is a partner that has licensed an Antengene TCE candidate, benefiting from potential pipeline expansion.
Jul 20, 2026 · 6 articles
80 UCB signed drug pricing deal United StatesTrump announces nine new...
60 UCB donated active pharmaceutical ingredients United StatesTrump announces nine new...
ERGEN INTELLIGENCE
Track UCB live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.